Contact
Please use this form to send email to PR contact of this press release:
Amal Therapeutics Raises CHF 3 Million in a Series A Financing Round Led by Boehringer Ingelheim Venture Fund
TO:
Please use this form to send email to PR contact of this press release:
Amal Therapeutics Raises CHF 3 Million in a Series A Financing Round Led by Boehringer Ingelheim Venture Fund
TO: